文献速递头颈外科

基于探针的荧光剂量测定法识别头颈癌:荧光引导组织预选的第一步

Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment.
PubMed 文献 · Head Neck · 2019-10-01

共获取216个数据点,肿瘤组织荧光与激发比值超过正常组织三倍以上,肿瘤检测曲线下面积为0.86(95%CI:0.81-0.91)。荧光引导组织预选可能对冰冻切片分析的组织采样产生重大影响并减少采样误差。

要点

  • 接触式探针荧光剂量仪可定量IRDye800CW,在离体头颈鳞癌组织中区分肿瘤与正常组织。
  • 肿瘤组织荧光与激发比值超过正常组织三倍以上,肿瘤检测AUC为0.86(95%CI:0.81-0.91)。
  • 荧光引导组织预选有望改善冰冻切片分析的组织采样并减少采样误差。

核心结论

  • 基于探针的荧光剂量测定法可定量帕尼单抗-IRDye800CW,在离体头颈鳞癌标本中有效区分肿瘤与正常组织。

主要发现

  • 肿瘤组织的荧光与激发比值超过正常组织三倍以上。
  • 肿瘤检测的曲线下面积为0.86(95%CI:0.81-0.91)。

关键数值与推荐

  • 肿瘤检测的曲线下面积为0.86(95%CI:0.81-0.91)。
  • 肿瘤组织荧光与激发比值超过正常组织三倍以上。

临床怎么用

  • 荧光引导组织预选可能对冰冻切片分析的组织采样产生重大影响,并可能减少采样误差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the rapid growth of fluorescence imaging, accurate sampling of tissue sections remains challenging. Development of novel technologies to improve intraoperative assessment of tissue is needed. METHODS: A novel contact probe-based fluorescence dosimeter device, optimized for IRDye800CW quantification, was developed. After evaluation of the device in a phantom setup, its clinical value was defined ex vivo in patients with head and neck squamous cell carcinoma who received panitumumab-IRDye800CW. RESULTS: Ten patients were enrolled with a total of 216 data points obtained. Final histopathology showed tumor in 119 spots and normal tissue in 97 spots. Fluorescence-to-excitation ratios in tumor tissue were more than three times higher than those in normal tissue. The area under the curve was 0.86 (95% CI: 0.81-0.91) for tumor detection. CONCLUSIONS: Fluorescence-guided tissue preselection using a fluorescence dosimeter could have substantial impact on tissue sampling for frozen section analysis and potentially reduce sampling errors.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Nishio N, van Keulen S, van den Berg NS, et al. Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment. Head Neck. 2019. PMID: 31571335. doi:10.1002/hed.25964

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。